196 related articles for article (PubMed ID: 16634640)
1. r-VKORC1 expression in factor IX BHK cells increases the extent of factor IX carboxylation but is limited by saturation of another carboxylation component or by a shift in the rate-limiting step.
Hallgren KW; Qian W; Yakubenko AV; Runge KW; Berkner KL
Biochemistry; 2006 May; 45(17):5587-98. PubMed ID: 16634640
[TBL] [Abstract][Full Text] [Related]
2. Carboxylase overexpression effects full carboxylation but poor release and secretion of factor IX: implications for the release of vitamin K-dependent proteins.
Hallgren KW; Hommema EL; McNally BA; Berkner KL
Biochemistry; 2002 Dec; 41(50):15045-55. PubMed ID: 12475254
[TBL] [Abstract][Full Text] [Related]
3. Tethered processivity of the vitamin K-dependent carboxylase: factor IX is efficiently modified in a mechanism which distinguishes Gla's from Glu's and which accounts for comprehensive carboxylation in vivo.
Stenina O; Pudota BN; McNally BA; Hommema EL; Berkner KL
Biochemistry; 2001 Aug; 40(34):10301-9. PubMed ID: 11513608
[TBL] [Abstract][Full Text] [Related]
4. Enhanced functional recombinant factor IX production by human embryonic kidney cells engineered to overexpress VKORC1.
Pakdaman SF; Vatandoost J; Bos MHA
Biotechnol Prog; 2020 Mar; 36(2):e2938. PubMed ID: 31677255
[TBL] [Abstract][Full Text] [Related]
5. VKOR paralog VKORC1L1 supports vitamin K-dependent protein carboxylation in vivo.
Lacombe J; Rishavy MA; Berkner KL; Ferron M
JCI Insight; 2018 Jan; 3(1):. PubMed ID: 29321368
[TBL] [Abstract][Full Text] [Related]
6. Engineering of a recombinant vitamin K-dependent gamma-carboxylation system with enhanced gamma-carboxyglutamic acid forming capacity: evidence for a functional CXXC redox center in the system.
Wajih N; Sane DC; Hutson SM; Wallin R
J Biol Chem; 2005 Mar; 280(11):10540-7. PubMed ID: 15640149
[TBL] [Abstract][Full Text] [Related]
7. Increased production of functional recombinant human clotting factor IX by baby hamster kidney cells engineered to overexpress VKORC1, the vitamin K 2,3-epoxide-reducing enzyme of the vitamin K cycle.
Wajih N; Hutson SM; Owen J; Wallin R
J Biol Chem; 2005 Sep; 280(36):31603-7. PubMed ID: 16030016
[TBL] [Abstract][Full Text] [Related]
8. GGCX mutants that impair hemostasis reveal the importance of processivity and full carboxylation to VKD protein function.
Rishavy MA; Hallgren KW; Wilson LA; Hiznay JM; Runge KW; Berkner KL
Blood; 2022 Oct; 140(15):1710-1722. PubMed ID: 35767717
[TBL] [Abstract][Full Text] [Related]
9. The inhibitory effect of calumenin on the vitamin K-dependent gamma-carboxylation system. Characterization of the system in normal and warfarin-resistant rats.
Wajih N; Sane DC; Hutson SM; Wallin R
J Biol Chem; 2004 Jun; 279(24):25276-83. PubMed ID: 15075329
[TBL] [Abstract][Full Text] [Related]
10. Vitamin K-dependent carboxylation.
Berkner KL
Vitam Horm; 2008; 78():131-56. PubMed ID: 18374193
[TBL] [Abstract][Full Text] [Related]
11. Disulfide-dependent protein folding is linked to operation of the vitamin K cycle in the endoplasmic reticulum. A protein disulfide isomerase-VKORC1 redox enzyme complex appears to be responsible for vitamin K1 2,3-epoxide reduction.
Wajih N; Hutson SM; Wallin R
J Biol Chem; 2007 Jan; 282(4):2626-35. PubMed ID: 17124179
[TBL] [Abstract][Full Text] [Related]
12. Warfarin alters vitamin K metabolism: a surprising mechanism of VKORC1 uncoupling necessitates an additional reductase.
Rishavy MA; Hallgren KW; Wilson L; Singh S; Runge KW; Berkner KL
Blood; 2018 Jun; 131(25):2826-2835. PubMed ID: 29592891
[TBL] [Abstract][Full Text] [Related]
13. The vitamin K-dependent carboxylase.
Berkner KL
Annu Rev Nutr; 2005; 25():127-49. PubMed ID: 16011462
[TBL] [Abstract][Full Text] [Related]
14. Expression of biologically active human clotting factor IX in Drosophila S2 cells: γ-carboxylation of a human vitamin K-dependent protein by the insect enzyme.
Vatandoost J; Zomorodipour A; Sadeghizadeh M; Aliyari R; Bos MH; Ataei F
Biotechnol Prog; 2012; 28(1):45-51. PubMed ID: 22012919
[TBL] [Abstract][Full Text] [Related]
15. The carboxylation efficiency of the vitamin K-dependent clotting factors: studies with factor IX.
Blostein M; Cuerquis J; Landry S; Galipeau J
Haemophilia; 2008 Sep; 14(5):1063-8. PubMed ID: 18680528
[TBL] [Abstract][Full Text] [Related]
16. Vitamin K 2,3-epoxide reductase and the vitamin K-dependent gamma-carboxylation system.
Wallin R; Sane DC; Hutson SM
Thromb Res; 2002 Nov; 108(4):221-6. PubMed ID: 12617985
[TBL] [Abstract][Full Text] [Related]
17. Isolation of the human gamma-carboxylase and a gamma-carboxylase-associated protein from factor IX-expressing mammalian cells.
Lingenfelter SE; Berkner KL
Biochemistry; 1996 Jun; 35(25):8234-43. PubMed ID: 8679578
[TBL] [Abstract][Full Text] [Related]
18. Confirmation of warfarin resistance of naturally occurring VKORC1 variants by coexpression with coagulation factor IX and in silico protein modelling.
Müller E; Keller A; Fregin A; Müller CR; Rost S
BMC Genet; 2014 Feb; 15():17. PubMed ID: 24491178
[TBL] [Abstract][Full Text] [Related]
19. Vitamin K-dependent carboxylation of the carboxylase.
Berkner KL; Pudota BN
Proc Natl Acad Sci U S A; 1998 Jan; 95(2):466-71. PubMed ID: 9435215
[TBL] [Abstract][Full Text] [Related]
20. Vitamin K epoxide reductase significantly improves carboxylation in a cell line overexpressing factor X.
Sun YM; Jin DY; Camire RM; Stafford DW
Blood; 2005 Dec; 106(12):3811-5. PubMed ID: 16081695
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
